190 related articles for article (PubMed ID: 32249346)
1. Toxicokinetics and toxicodynamics of the fentanyl homologs cyclopropanoyl-1-benzyl-4´-fluoro-4-anilinopiperidine and furanoyl-1-benzyl-4-anilinopiperidine.
Gampfer TM; Wagmann L; Park YM; Cannaert A; Herrmann J; Fischmann S; Westphal F; Müller R; Stove CP; Meyer MR
Arch Toxicol; 2020 Jun; 94(6):2009-2025. PubMed ID: 32249346
[TBL] [Abstract][Full Text] [Related]
2. Toxicokinetic Studies and Analytical Toxicology of the New Synthetic Opioids Cyclopentanoyl-Fentanyl and Tetrahydrofuranoyl-Fentanyl.
Gampfer TM; Wagmann L; Richter MJ; Fischmann S; Westphal F; Meyer MR
J Anal Toxicol; 2020 Apr; 44(5):449-460. PubMed ID: 32020187
[TBL] [Abstract][Full Text] [Related]
3. Toxicokinetics and analytical toxicology of the abused opioid U-48800 - in vitro metabolism, metabolic stability, isozyme mapping, and plasma protein binding.
Gampfer TM; Richter LHJ; Schäper J; Wagmann L; Meyer MR
Drug Test Anal; 2019 Oct; 11(10):1572-1580. PubMed ID: 31424163
[TBL] [Abstract][Full Text] [Related]
4. Studies on the metabolism of the fentanyl-derived designer drug butyrfentanyl in human in vitro liver preparations and authentic human samples using liquid chromatography-high resolution mass spectrometry (LC-HRMS).
Steuer AE; Williner E; Staeheli SN; Kraemer T
Drug Test Anal; 2017 Jul; 9(7):1085-1092. PubMed ID: 27736030
[TBL] [Abstract][Full Text] [Related]
5. How to Study the Metabolism of New Psychoactive Substances for the Purpose of Toxicological Screenings-A Follow-Up Study Comparing Pooled Human Liver S9, HepaRG Cells, and Zebrafish Larvae.
Wagmann L; Frankenfeld F; Park YM; Herrmann J; Fischmann S; Westphal F; Müller R; Flockerzi V; Meyer MR
Front Chem; 2020; 8():539. PubMed ID: 32766204
[TBL] [Abstract][Full Text] [Related]
6. Zebrafish early life stages as alternative model to study 'designer drugs': Concordance with mammals in response to opioids.
Kirla KT; Erhart C; Groh KJ; Stadnicka-Michalak J; Eggen RIL; Schirmer K; Kraemer T
Toxicol Appl Pharmacol; 2021 May; 419():115483. PubMed ID: 33722667
[TBL] [Abstract][Full Text] [Related]
7. Qualitative studies on the metabolism and the toxicological detection of the fentanyl-derived designer drugs 3-methylfentanyl and isofentanyl in rats using liquid chromatography-linear ion trap-mass spectrometry (LC-MS(n)).
Meyer MR; Dinger J; Schwaninger AE; Wissenbach DK; Zapp J; Fritschi G; Maurer HH
Anal Bioanal Chem; 2012 Jan; 402(3):1249-55. PubMed ID: 22065349
[TBL] [Abstract][Full Text] [Related]
8. Metabolism and cytotoxicity studies of the two hallucinogens 1cP-LSD and 4-AcO-DET in human liver and zebrafish larvae models using LC-HRMS/MS and a high-content screening assay.
Gampfer TM; Schütz V; Schippers P; Rasheed S; Baumann J; Wagmann L; Pulver B; Westphal F; Flockerzi V; Müller R; Meyer MR
J Pharm Biomed Anal; 2024 Aug; 245():116187. PubMed ID: 38692215
[TBL] [Abstract][Full Text] [Related]
9. Toxicokinetics and Analytical Toxicology of Flualprazolam: Metabolic Fate, Isozyme Mapping, Human Plasma Concentration and Main Urinary Excretion Products.
Wagmann L; Manier SK; Bambauer TP; Felske C; Eckstein N; Flockerzi V; Meyer MR
J Anal Toxicol; 2020 Jul; 44(6):549-558. PubMed ID: 32104896
[TBL] [Abstract][Full Text] [Related]
10. In vitro Characterization of NPS Metabolites Produced by Human Liver Microsomes and the HepaRG Cell Line Using Liquid Chromatographyhigh Resolution Mass Spectrometry (LC-HRMS) Analysis: Application to Furanyl Fentanyl.
Richeval C; Gicquel T; Hugbart C; Le Dare B; Allorge D; Morel I; Gaulier JM
Curr Pharm Biotechnol; 2017; 18(10):806-814. PubMed ID: 29173157
[TBL] [Abstract][Full Text] [Related]
11. Metabolism of the active metabolite of quetiapine, N-desalkylquetiapine in vitro.
Bakken GV; Molden E; Knutsen K; Lunder N; Hermann M
Drug Metab Dispos; 2012 Sep; 40(9):1778-84. PubMed ID: 22688609
[TBL] [Abstract][Full Text] [Related]
12. Identification of human liver cytochrome P-450 3A4 as the enzyme responsible for fentanyl and sufentanil N-dealkylation.
Tateishi T; Krivoruk Y; Ueng YF; Wood AJ; Guengerich FP; Wood M
Anesth Analg; 1996 Jan; 82(1):167-72. PubMed ID: 8712396
[TBL] [Abstract][Full Text] [Related]
13. In Vitro Metabolism and Hepatic Intrinsic Clearance of the Synthetic Cannabinoid Receptor Agonist JWH-122 and Its Four ω-Halogenated Analogues.
Davidsen AB; Mardal M; Linnet K
AAPS J; 2019 May; 21(4):63. PubMed ID: 31093790
[TBL] [Abstract][Full Text] [Related]
14. Metabolism of fentanyl, a synthetic opioid analgesic, by human liver microsomes. Role of CYP3A4.
Feierman DE; Lasker JM
Drug Metab Dispos; 1996 Sep; 24(9):932-9. PubMed ID: 8886601
[TBL] [Abstract][Full Text] [Related]
15. In vitro metabolism of the novel synthetic opioid agonist cyclopropylfentanyl and subsequent confirmation in authentic human samples using liquid chromatography-high resolution mass spectrometry.
Cutler C; Hudson S
Drug Test Anal; 2019 Aug; 11(8):1134-1143. PubMed ID: 31081594
[TBL] [Abstract][Full Text] [Related]
16. In vitro functional characterization of a panel of non-fentanyl opioid new psychoactive substances.
Vandeputte MM; Cannaert A; Stove CP
Arch Toxicol; 2020 Nov; 94(11):3819-3830. PubMed ID: 32734307
[TBL] [Abstract][Full Text] [Related]
17. Phenethylamine-derived new psychoactive substances 2C-E-FLY, 2C-EF-FLY, and 2C-T-7-FLY: Investigations on their metabolic fate including isoenzyme activities and their toxicological detectability in urine screenings.
Wagmann L; Hempel N; Richter LHJ; Brandt SD; Stratford A; Meyer MR
Drug Test Anal; 2019 Oct; 11(10):1507-1521. PubMed ID: 31299701
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the biotransformation pathways of clomiphene, tamoxifen and toremifene as assessed by LC-MS/(MS) following in vitro and excretion studies.
Mazzarino M; Biava M; de la Torre X; Fiacco I; Botrè F
Anal Bioanal Chem; 2013 Jun; 405(16):5467-87. PubMed ID: 23604525
[TBL] [Abstract][Full Text] [Related]
19. Flubromazolam-Derived Designer Benzodiazepines: Toxicokinetics and Analytical Toxicology of Clobromazolam and Bromazolam.
Wagmann L; Manier SK; Felske C; Gampfer TM; Richter MJ; Eckstein N; Meyer MR
J Anal Toxicol; 2021 Nov; 45(9):1014-1027. PubMed ID: 33048135
[TBL] [Abstract][Full Text] [Related]
20. Metabolic fate of the new synthetic cannabinoid 7'N-5F-ADB in rat, human, and pooled human S9 studied by means of hyphenated high-resolution mass spectrometry.
Richter LHJ; Maurer HH; Meyer MR
Drug Test Anal; 2019 Feb; 11(2):305-317. PubMed ID: 30160067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
